|
|
|
|
|
|
|
|
|
|
Merrimack Pharmaceuticals
"Through this approach we hope to generate additional knowledge on how ErbB3 signaling affects response to therapy, and then apply this understanding to identify patients that will most likely benefit from treatment regimens that include MM-121."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.